The international effort to build the world’s largest fusion reactor in southern France has entered a critical new phase, with project leaders adopting a revised 2024 baseline that acknowledges years ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...